Work

Patient-reported symptoms and impacts of locally advanced or metastatic urothelial cancer (la/mUC) after chemotherapy followed by a PD-1/PD-L1 checkpoint inhibitor (CPI).

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.7_suppl.380

Authors: Manasee Shah, Jacob Devine, Sam Wang, Zsolt Hepp, Sonali Shah

Institutions: Astellas Pharma (United States), Seagen (United States)

Language: English

Topic: Cancer survivorship and care

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2921064724

Cites:

Cited by: 3

Related to: 10